Loading...
Akoya Biosciences, Inc.
AKYA•NASDAQ
Healthcare
Medical - Instruments & Supplies
$1.29
$-0.07(-5.15%)
Akoya Biosciences, Inc. (AKYA) Financial Performance & Income Statement Overview
Review Akoya Biosciences, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-15.48%
↓ 15.48%
Operating Income Growth
18.97%
↑ 18.97%
Net Income Growth
12.57%
↑ 12.57%
Operating Cash Flow Growth
13.35%
↑ 13.35%
Operating Margin
-48.22%
↓ 48.22%
Gross Margin
61.74%
↑ 61.74%
Net Profit Margin
-59.45%
↓ 59.45%
ROE
-505.83%
↓ 505.83%
ROIC
-844.25%
↓ 844.25%
Akoya Biosciences, Inc. (AKYA) Income Statement & Financial Overview
Review Akoya Biosciences, Inc.'s (AKYA) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $21.34M | $18.81M | $23.16M | $18.35M |
| Cost of Revenue | $6.96M | $7.09M | $9.78M | $9.97M |
| Gross Profit | $14.39M | $11.72M | $13.39M | $8.38M |
| Gross Profit Ratio | $0.67 | $0.62 | $0.58 | $0.46 |
| R&D Expenses | $4.43M | $4.47M | $5.29M | $5.55M |
| SG&A Expenses | $15.69M | $14.67M | $19.09M | $19.86M |
| Operating Expenses | $20.12M | $20.07M | $24.38M | $25.42M |
| Total Costs & Expenses | $27.07M | $27.16M | $34.16M | $35.39M |
| Interest Income | $380000.00 | $521000.00 | $668000.00 | $937000.00 |
| Interest Expense | $2.59M | $2.63M | $2.61M | $2.61M |
| Depreciation & Amortization | $2.09M | $1.82M | $1.93M | $2.05M |
| EBITDA | -$3.77M | -$6.04M | -$8.57M | -$18.76M |
| EBITDA Ratio | -$0.18 | -$0.32 | -$0.37 | -$1.02 |
| Operating Income | -$5.71M | -$8.35M | -$11.08M | -$17.04M |
| Operating Income Ratio | -$0.27 | -$0.44 | -$0.48 | -$0.93 |
| Other Income/Expenses (Net) | -$2.50M | -$2.14M | -$2.02M | -$1.84M |
| Income Before Tax | -$8.21M | -$10.49M | -$13.10M | -$23.42M |
| Income Before Tax Ratio | -$0.38 | -$0.56 | -$0.57 | -$1.28 |
| Income Tax Expense | -$8000.00 | $44000.00 | $47000.00 | $63000.00 |
| Net Income | -$8.20M | -$10.53M | -$13.15M | -$23.48M |
| Net Income Ratio | -$0.38 | -$0.56 | -$0.57 | -$1.28 |
| EPS | -$0.17 | -$0.21 | -$0.27 | -$0.48 |
| Diluted EPS | -$0.17 | -$0.21 | -$0.27 | -$0.48 |
| Weighted Avg Shares Outstanding | $49.56M | $49.50M | $49.42M | $49.19M |
| Weighted Avg Shares Outstanding (Diluted) | $49.56M | $49.50M | $49.42M | $49.19M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan